Animal models

Animal testing
#Animal models #Animal testing #Cellular assays #FDA #Organoids #Preclinical investigations

FDA Modernization Act 2.0: A step in the right direction

By DDW Editor Reece Armstrong A lot has already been said about the US Food and Drug Administration’s (FDA) Modernization Act 2.0 and for good reason. The decision by the Biden administration to end the federal requirement for drugs under development to be tested on animals represents a significant step forward for the… Read More

#Exclusive Content

Cancer research
#Animal models #Cancer research #Cancer treatment #Oncology #The Institute of Cancer Research

First-in-class HSF1 pathway drug shrinks tumours in mice

A new, oral, first-in-class experimental cancer drug has shown potent activity against cancer cells and caused shrinkage of hard-to-treat human ovarian tumours grown in mice, a new study shows. The drug, which is now called NXP800 and has already entered a Phase I clinical trial, was… Read More

#Cancer Research #News

Arthritis
#Animal models #Arthritis #Autoimmune disease #Immune response #Immune system #University of Southern California

‘Regenerative’ osteoarthritis drug moves to clinical trial

A team of researchers at the Keck School of Medicine of University of Southern California (USC) have found a drug with the potential for curbing painful hyperinflammation from osteoarthritis, according to results of an animal study. The findings indicate that a drug compound, R805/CX-011, may modulate… Read More

#Editor's Choice #News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

Weekly drug discovery highlights podcast: Listen now

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In the news this week, we have covered a number of early-stage studies that could… Read More

#News

#Animal models #Cancer research #Drug discovery #Immune response #Long Covid #mRNA #Oncology #Preclinical investigations

This week in drug discovery (13-17 March)

News round-up for 13-17 March by DDW Digital Content Editor Diana Spencer.  In the news this week we have covered a number of early-stage studies that could lead to potentially huge breakthroughs in the treatment of metastatic breast cancer, long Covid, bacterial diseases, bone cancer, and autoimmune… Read More

#News

Artificial sweetener
#Animal models #Autoimmune disease #Francis Crick Institute #Immune response #T cell activation

Artificial sweetener dampened T cell response in mice

Scientists at the Francis Crick Institute have found that high consumption of a common artificial sweetener, sucralose, lowers activation of T cells in mice. If found to have similar effects in humans, one day it could be used therapeutically to help dampen T cell responses. For… Read More

#News

#Animal models #Animal testing #Drug discovery #Drug safety #FDA #Regulatory

What does the FDA animal testing legislation mean for drug discovery? 

As of late December 2022, the US Food and Drug Administration (FDA) no longer needs drugs to be tested in animals to receive approval, according to legislation signed by President Joe Biden1 – the Modernization Act 2.0. This news has been shared widely as a landmark moment, especially in the eyes… Read More

#Business & Investment #Exclusive Content #Opinion #Regulatory #Trends & Analysis

AAV gene therapy
#AAV #Animal models #CANbridge Pharmaceuticals #Cell and gene therapy #China #Gene therapy #License agreement #Muscular dystrophy

Chinese biotech company consolidates gene therapy portfolio

CANbridge Pharmaceuticals has exercised its option to secure the exclusive global rights to develop, manufacture and commercialise a novel gene therapy to treat spinal muscular atrophy (SMA) from UMass Chan Medical School.  Animal data presented in 2022 showed that the gene therapy outperformed the benchmark therapy along… Read More

#News

Neurons in a brain with Alzheimer's disease
#Alzheimer's #Animal models #Neurodegenerative disorders #University of Glasgow

Hope for drug that slows neurodegenerative disease

Scientists have found a new drug treatment that can slow the progression of neurodegenerative disease in mice. The breakthrough research may offer fresh hope in tackling currently untreatable conditions such as Alzheimer’s disease (AD).  The study was led by researchers at the University of Glasgow’s new Advanced… Read More

#Editor's Choice #News

#Animal models #Biology #Drug discovery #MPS technology #Podcast

Podcast: The role of animals in the future of drug discovery

This is the latest episode of the free DDW podcast, “The role of animals in the future of drug discovery”. It covers two articles written for Volume 22, Issue 4 – Fall 2021 of DDW, narrated by DDW Multimedia Editor Megan Thomas. They are called “How an animal model… Read More

#News

A laboratory mouse
#Animal models #Animal testing #Genetic editing #Genetics #Phenotyping

NIH renews knockout mouse project for 3rd time

The University of California, Davis, has received over $12 million from the National Institutes of Health for the third and final five-year phase of the Knockout Mouse Phenotyping Project (KOMP2). ‘Knockout’ mice are bred in a laboratory with specific genes silenced or ‘knocked out’. They have been valuable tools for… Read More

#News

#Animal models #Cell therapy #Humanised Immune System (HIS) #Immunotherapy

Mice with humanised immune systems advance cell-based immunotherapy

Listen to this article on the DDW Podcast: By Courtney Ferrebee, PhD, Field Applications Scientist, Taconic Biosciences. Although immunotherapy has revolutionised cancer therapy, the effectiveness of currently available immunotherapies varies significantly across patients and treatment types. As a result, researchers are striving to continually improve immuno-oncology approaches using the patient's own… Read More

#Exclusive Content

#Animal models #Data #Genetics / genomics

Can animal genomics help find therapies for human disease?

Listen to this article on the DDW Podcast: Lu Rahman spoke to Ashley Zehnder, CEO of Fauna Bio, a biotech harnessing the power of comparative and functional animal genomics to find better therapies for human disease, including neurologic, metabolic, fibrotic and cardiovascular disorders. "Comparative genomics is the process of using data… Read More

#Exclusive Content

#Animal models #Animal testing #Drug research #Regulatory

Animal research: reinventing the norm

Listen to this article on the DDW Podcast: FRAME (Fund for the Replacement of Animals in Medical Experiments) Education and Outreach Manager Amy Beale discusses how current legislative and regulatory requirements for animal research could be strengthened to help prevent animal experiments and accelerate change. She also considers the factors influencing… Read More

#Exclusive Content #Opinion #Regulatory

#Animal models #Animal testing #Life sciences

How an animal model provider can save your resources 

Listen to this article on the DDW Podcast: John Couse, PhD, Vice President, Scientific Services, Taconic Biosciences, explains how focussing on best practices for animal models can reduce a project’s timeline, budget, and total number of animals used.   Research organisations engaged in drug discovery rely on animal models, including genetically… Read More

#Business & Investment #Exclusive Content #Opinion

#Academic #AI / data analytics / healthtech / informatics #Animal models #Biomarkers #Business #Cell therapy #Cellular & Molecular biology #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Combinatorial chemistry #Drug development #Drug discovery #Drug repositioning #Gene therapy #Genetics / genomes #High Content Screening #High throughput screening #Immunology #Immunology / Virology & Vaccines #Lead discovery #Molecular medicine #PCR #RNA #Screening #Stem cells #System biology #Systems biology #Therapeutics #Translational #Translational chemistry

Race To COVID-19 cure – the Core Model for solving the pandemic crisis (Part 1 & 2)

By Ibis Sanchez-Serrano and Rathnam Chaguturu Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes this disease. This article examines the major initiatives being explored at the public policy level to… Read More

#Covid-19 #Exclusive Content